Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 3.3B | 3.2B | 3.4B | 3.5B |
Cost of revenue | 2.7B | 2.6B | 2.7B | 2.8B |
Gross profit | 654M | 626M | 659M | 754M |
Operating expense | ||||
Research & development | 27M | 27M | 28M | 26M |
Selling general and admin | 303M | 295M | 315M | 329M |
Other operating expenses | -21M | -26M | -2M | -11M |
Operating income | 345M | 330M | 318M | 410M |
Non operating interest income | ||||
Income | 10M | 9M | 11M | 7M |
Expense | 85M | 81M | 86M | 85M |
Other income expense | -33M | -34M | -7M | -14M |
Pretax income | 237M | 224M | 236M | 318M |
Tax provision | 40M | 58M | 43M | 56M |
Net income | 197M | 167M | 193M | 261M |
Basic EPS | 0.1 | 0.1 | 0.1 | 0.2 |
Diluted EPS | 0.1 | 0.1 | 0.1 | 0.2 |
Basic average shares | 931.6M | 931.6M | 929.7M | 929.0M |
Diluted average shares | 933.5M | 933.5M | 932.2M | 931.6M |
EBITDA | 486M | 464M | 469M | 565M |
Net income from continuing op. | 197M | 167M | 193M | 261M |
Minority interests | -1M | -4M | -2M | -4M |
Preferred stock dividends | 0 | 0 | 1M | 1M |